Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes
Abstract Objectives We compared the treatment effectiveness between guselkumab and adalimumab in patients with pustulotic arthro-osteitis (PAO). In addition, we performed peripheral blood immunophenotyping to elucidate the immunological background and analyzed the impact of therapeutic drugs to veri...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2022-10-01
|
| Серія: | Arthritis Research & Therapy |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13075-022-02934-3 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|